Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Going Viral: How to Find & Engage Your Audience to Become a Podcast Celebrity

Jason Liebowitz, MD, FACR  |  January 9, 2024

Mrs. Crow noted that content styles can vary and should reflect the strengths of the content creator. Example: She has a more outgoing personality and good sense of humor. Thus, she makes videos and audio clips that are more fun and entertaining. Other creators may focus on producing content that is inspirational, purely educational or even controversial at times.

Mrs. Crow explained that social media should encourage a dialogue between the podcaster and listeners. It’s important for hosts to solicit and respond to feedback, engage with listeners, use listener suggestions to guide future content creation and ask listeners to help spread the word about the podcast.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Going Viral

The session’s final speaker was Paul Sufka, MD, a rheumatologist at Twin Cities Orthopedics, Eagan, Minn., who discussed the viral strategies used for the COVID-19 Global Rheumatology Alliance.

In March 2020, Leonard Calabrese, DO, vice chair of Cleveland Clinic’s Department of Rheumatic and Immunologic Diseases, suggested via Twitter (now X) that rheumatologists create a secure registry that could be used by patients and providers to catalog cases of COVID-19 infection in individuals with rheumatic diseases. Dr. Sufka joined others to help make this happen. Within months, more than 30,000 cases had been reported through the registry.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The success of this effort demonstrated several important steps necessary when seeking to go viral: establish a website to direct online traffic to the product, use various forms of social media, create an email list serve to communicate with stakeholders and reach out to partner organizations to help spread the word. A registry, such as the one developed by Dr. Sufka and colleagues, should create its own brand with an engaging name and logo, just as a podcaster would. The COVID-19 Global Rheumatology Alliance has continued to be hugely successful and the lessons learned from its creation and deployment can guide those in podcasting and social media.

It’s no surprise that this session was a hit. Each speaker was charismatic, thoughtful and experienced. Hopefully, the session inspired attendees to pursue their own podcasting dreams.


Jason Liebowitz, MD, is an assistant professor of medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons, New York.

Reference

  1. Rundles RW. Effects of allopurinol on 6-mercaptopurine therapy in neoplastic diseases. Ann Rheum Dis. 1966 Nov;25(6 Suppl):655-656.
  2. The mechanism and drug interaction—allopurinol and azathioprine and risk of bone marrow suppression. EBM Consult LLC. 2024.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceCareerMeeting Reports Tagged with:ACR Convergence 2023ACR on Airpodcast

Related Articles
    Diagnosis Can Be Elusive for Fever of Unknown Origin

    Diagnosis Can Be Elusive for Fever of Unknown Origin

    March 15, 2016

    Settling into room 501 at Maine Medical Center, Mrs. N was on her way to the bathroom when she felt it coming on. One moment she was okay; the next, her chest felt damp and cold, even as her face flushed and her temperature spiked. Her forehead glistened beads of warm sweat. She felt the…

    Bridge the Gap Between Goal and Attainment

    May 1, 2010

    Use motivational interviewing to facilitate behavior change for your clients

    Monkey Business Images/shutterstock.com

    Assessing Autoimmune Disease Symptoms in Silicone Breast Implant Recipients

    December 15, 2016

    My nurse, Joanne, took me aside before I began my next consult. “Room No. 5, breast implant patient. Her lawyer organized the records.” She handed me a hefty three-ring notebook organized by color-coded tabs. “Her attorney called just now,” Joanne raised an eyebrow, “and told me to tell you that, to save time, he highlighted…

    ACR on Air: New Rheumatology Podcast Introduced

    September 2, 2019

    A new podcast from the ACR provides in-depth discussions about newly published science, regulatory updates, advocacy and volunteer opportunities for the rheumatology community…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences